| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $39.0M | +255.1% |
| R&D Expense | $84.4M | +28.9% |
| SG&A Expense | $17.8M | +4.1% |
| Operating Income | -$65.5M | +11.0% |
| Interest Expense | $1.7M | -39.6% |
| Income Tax | $4.4M | — |
| Net Income | -$69.5M | +8.9% |
| EPS (Basic) | -$0.46 | +44.6% |
| EPS (Diluted) | -$0.46 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.8M | -71.8% |
| Short-term Investments | $116.1M | +152.3% |
| Accounts Receivable | $1.4M | +50.4% |
| Current Assets | $151.1M | -5.9% |
| Total Assets | $195.4M | -4.4% |
| Current Liabilities | $32.9M | +192.8% |
| Long-term Debt | $0 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.4M | +47.6% |
| Capital Expenditures | $512K | -36.7% |
| Investing Cash Flow | -$74.9M | -491.1% |
| Financing Cash Flow | $31.8M | -76.8% |
| Free Cash Flow | -$35.9M | +47.5% |
| +44.6% |
| Total Liabilities |
| $58.6M |
| +67.1% |
| Stockholders' Equity | $136.9M | -19.2% |